摘要
目的:评价普米克令舒和沐舒坦雾化吸入治疗毛细支气管炎疗效与安全性.方法:选择毛细支气管炎60例,随机分为治疗组30例,除常规抗感染、激素、对症等常规治疗外,辅以普米克令舒和沐舒坦雾化吸入治疗;对照组30例只采用常规治疗。临床观察气急缓解时间、喘鸣音消失时间及总有效率.结果:治疗组均明显优于对照组,经统计学检验差异有显著性(P<0.01).结论:普米克令舒和沐舒坦雾化吸入治疗毛细支气管炎疗效显著,方法简便.
Objective： To compare the effect of inhalation therapy of Pulmicort and ambroxol in the treatment of bronchiolitis. Methods 60 cases of bronchiolitis were randomly divided into observation group （30cases） and control group（30cases）, observation group with Pulmicort and ambroxol, control group with routine treatment, to observe the duration of their symptoms, the time of wheezing vanishing and the overall efficacy rate. Results Observation group is of obvious efficacy compared with control group. There is significant difference （P〈0.01） by statistics.. Conclusion The inhalation therapy of Pulmicort and ambroxol is convenient、 safe and effective in the treatment of bronchiolitis.
出处
《黑龙江医药》
CAS
2007年第6期633-634,共2页
Heilongjiang Medicine journal
